Amiodarone-induced thyrotoxicosis

被引:6
|
作者
Schubert, Louis [1 ]
Bricaire, Leopoldine [1 ]
Groussin, Lionel [1 ,2 ,3 ]
机构
[1] Hop Cochin, AP HP, Serv Endocrinol, F-75014 Paris, France
[2] Univ Paris, F-75014 Paris, France
[3] Inst Cochin, Inserm Unite 1016, CNRS UMR 8104, F-75014 Paris, France
关键词
Amiodarone; Thyrotoxicosis; Hyperthyroidism; ASSOCIATION; GUIDELINES; MANAGEMENT; TYPE-2; THYROIDECTOMY; CONTINUATION; THERAPY;
D O I
10.1016/j.ando.2020.04.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians are sometimes faced with difficult diagnostic and therapeutic situations. The disease pathophysiology is partially understood, explaining the lack of predictive factors for occurrence. Different international recommendations for their management have been published: the most recent in 2018 by the European Thyroid Association (ETA) (Ross et al., 2016; Bartalena et al., 2018). The purpose of this paper is to present the essential concepts for their management and to review the literature since 2018. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:163 / 166
页数:4
相关论文
共 50 条
  • [21] Anaesthesia for amiodarone-induced thyrotoxicosis: A case review
    Sutherland, J
    Robinson, B
    Delbridge, L
    ANAESTHESIA AND INTENSIVE CARE, 2001, 29 (01) : 24 - 29
  • [22] Amiodarone-induced thyrotoxicosis treated by thyroidectomy.
    LeCosquer, P
    GuerinRobardey, AM
    Ossart, M
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1996, 15 (07): : 1092 - 1094
  • [23] Amiodarone-induced thyrotoxicosis after administration of an intravenous infusion of amiodarone
    Tohooloo, Bhavna
    Jhummon, Navina P.
    Qu, Shen
    CARDIOVASCULAR ENDOCRINOLOGY, 2013, 2 (03): : 63 - 65
  • [24] The role of plasmapheresis in the treatment of amiodarone-induced thyrotoxicosis
    Babic, Betty Korljan
    Ljutic, Dragan
    Brnic, Darko
    Dodig, Josipa
    DIALYSIS & TRANSPLANTATION, 2007, 36 (04) : 227 - 228
  • [25] The roles of thyroidectomy in patients with amiodarone-induced thyrotoxicosis: A systematic review
    Widiarti, Wynne
    Saputra, Pandit Bagus Tri
    Mustofa, Ali
    Meitavany, Estya Nadya
    Oktaviono, Yudi Her
    Alkaff, Firas Farisi
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (03)
  • [26] Amiodarone-Induced Thyrotoxicosis in a Patient with Autonomously Functioning Nodular Goiter
    Liang, Yi-Lin
    Huang, Shih-Ming
    Peng, Shu-Ling
    Hsiao, Shu-Hwa
    Hung, Hao-Chang
    Ou, Horng-Yih
    Wu, Ta-Jen
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (01) : 134 - 138
  • [27] Life-threatening amiodarone-induced thyrotoxicosis - Personalized approach to radical treatment
    Opalinska, Marta
    Pantoflinski, Jacek
    Sokolowski, Grzegorz
    Pach, Dorota
    Kostecka-Matyja, Marta
    Zabicka, Katarzyna
    Partynski, Bartosz
    Kiec-Klimczak, Malgorzata
    Sowa-Staszczak, Anna
    Buziak-Bereza, Monika
    Gilis-Januszewska, Aleksandra
    Hubalewska-Dydejczyk, Alicja
    HELIYON, 2024, 10 (14)
  • [28] Mixed Amiodarone-Induced Thyrotoxicosis Refractory to Medical Therapy and Plasmapheresis
    Kotwal, Anupam
    Touchan, Basel
    Seetharaman, Kavita Y.
    Haas, Richard Allen
    Lithgow, Marie
    Malkani, Samir
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 5 (03) : 220 - 223
  • [29] Amiodarone-induced type 2 thyrotoxicosis
    Portelli, Darryl
    Mifsud, Simon
    Abela, Alexia
    Fava, Stephen
    BMJ CASE REPORTS, 2021, 14 (01)
  • [30] Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction
    Maqdasy, Salwan
    Batisse-Lignier, Marie
    Auclair, Candy
    Desbiez, Francoise
    Citron, Bernard
    Thieblot, Philippe
    Roche, Beatrice
    Lusson, Jean Rene
    Tauveron, Igor
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (07) : 1112 - 1116